Alzheimer’s for Amateurs

Research Index entry · Trial

AR1001 missed its main goal in its final-stage trial

Evidence
People · final-stage trial · company data
Source
clinicaltrials.gov
Added
2 October 2026

What it is

AR1001 (mirodenafil) is a pill from the same drug family as Viagra. In AriBio’s final-stage POLARIS-AD trial of 1,535 people, it didn’t slow decline more than a placebo overall. The company points to a group the trial named in advance, the 604 people not already taking an older Alzheimer’s drug: their main memory-and-daily-life score declined 0.44 points less over a year, which AriBio calls 31 percent slower. More people quit the pill over side effects, mainly stomach trouble.

Where it stands

  1. Lab discovery
  2. Animal studies
  3. First studies in people
  4. Large trials
  5. Approved

The company’s own numbers, with the full data not out yet. AriBio plans to discuss them with the FDA.

Update timeline

What changed

Newest first. Only changes to the subject itself appear here: new information, or something proven wrong.

  1. Watching
    The Scouts look again every Friday

    Only new information or a correction shows up here, not another mention of the same thing.

  2. Update

Research connections

Why these belong together

A connection has to say what it adds. Shared keywords alone don’t count.

Educational, not medical advice. Spot something wrong? hello@alzamateurs.com